title: [Efficacy and safety of the substitution of zidovudine by nevirapine in treatments based on three nucleoside analogue reverse transcriptase inhibitors in HIV-1 infected patients].
authors.forename: Maria
authors.initials: M
authors.lastname: Tasias
authors.forename: Sheila
authors.initials: S
authors.lastname: Ruiz
authors.forename: Elisabet
authors.initials: E
authors.lastname: Deig
authors.forename: Enric
authors.initials: E
authors.lastname: Pedrol
mesh_terms: D000328:Adult; D018791:CD4 Lymphocyte Count; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000097:blood / Q000139:chemically induced; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019562:Viral Load; D015215:Zidovudine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005723:gamma-Glutamyltransferase / Q000097:blood; D000099227:Abacavir
chemical_list: D002784:Cholesterol; D008076:Cholesterol, HDL; D015224:Dideoxynucleosides; D054303:HIV Reverse Transcriptase; D019259:Lamivudine; D019829:Nevirapine; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D005723:gamma-Glutamyltransferase; D000099227:Abacavir; C514824:reverse transcriptase, Human immunodeficiency virus 1